DEUTSCHE BANK AG\ - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,234
-93.1%
2,464
-81.8%
0.00%
Q2 2023$90,203
-82.5%
13,544
-51.0%
0.00%
Q1 2023$516,229
-0.6%
27,665
+14.5%
0.00%
Q4 2022$519,193
+74.2%
24,171
-4.3%
0.00%
Q3 2022$298,000
-15.8%
25,258
-6.0%
0.00%
Q2 2022$354,000
-31.1%
26,876
+9.1%
0.00%
Q1 2022$514,000
-11.7%
24,629
-14.0%
0.00%
Q4 2021$582,000
-41.7%
28,627
-13.0%
0.00%
Q3 2021$999,000
+41.9%
32,894
+35.8%
0.00%
Q2 2021$704,000
-31.6%
24,224
+1.6%
0.00%
-100.0%
Q1 2021$1,029,000
-10.0%
23,835
-3.6%
0.00%0.0%
Q4 2020$1,143,000
+28.4%
24,734
+20.5%
0.00%0.0%
Q3 2020$890,000
-12.7%
20,519
+6.6%
0.00%0.0%
Q2 2020$1,020,000
+192.3%
19,257
+23.3%
0.00%
Q1 2020$349,000
+53.7%
15,618
-0.2%
0.00%
Q4 2019$227,000
+2170.0%
15,642
+820.7%
0.00%
Q3 2019$10,000
-79.6%
1,699
-62.6%
0.00%
Q2 2019$49,000
+157.9%
4,542
-11.7%
0.00%
Q4 2018$19,000
-59.6%
5,146
-17.0%
0.00%
Q3 2018$47,0006,2000.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders